Clinical Trial Update: A Trial of Folate With B12 in Patients With Schizophrenia With Residual Symptoms in Ethiopia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating folate with B12 in patients with residual schizophrenia symptoms conducted in Ethiopia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• folate with B12

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED